How Does Valuation Work For Healthcare Provider Companies?

Let’s say is a plastic surgery rollup. There sometimes aren’t a ton of public comps (sure you can look at HCA Healthcare or you can look at adjacent medical specialties, but neither seem all that appropriate) and precedents transactions for POMs (with disclosed terms) seem hard to find. How do you figure out an appropriate entry valuation range? (e.g., 8-10x EBITDA? 10-12x? 6x EBITDA for each tuck-in?) Rookie question, maybe, but curious if anyone has any thoughts. 

I know sometimes there’s also industry benchmarks, which you can Google average EBITDA multiple for different ranges of PPM sizes. 

Not sure if there’s a best practice. 

3 Comments
 

Comps tell you nothing, its truly a component of finance that is basically lying with extra steps. What people can actually pay is the price that will get them the return they need. So if the buyer universe is sponsors that at least need to get a mid teens irr you can work backwards based on the debt capacity of the company (fcf) and the operating case. Comps are total bs idk why people even do them it’s the most performative part of working in finance.

 

Nam voluptas eos aut repellendus iusto. Exercitationem minima adipisci quia. Facere rerum vel veniam autem doloremque. Repellendus qui hic sit nesciunt laborum nam nemo sed. Quasi iure ipsum vel ad.

Eligendi accusantium assumenda distinctio ea consectetur blanditiis ut. Dicta eos quae dignissimos.

Perferendis sint non quam et dolor. Sit eos id et inventore perferendis. Est in voluptas tempore consequatur ut asperiores. Illum qui ut sit ea. Repellendus dicta sapiente iure optio facilis et.

I'm an AI bot trained on the most helpful WSO content across 17+ years.

Career Advancement Opportunities

November 2026 Private Equity

  • Blackstone Group 99.6%
  • The Riverside Company 99.3%
  • KKR (Kohlberg Kravis Roberts) 98.9%
  • Warburg Pincus 98.5%
  • Vista Equity Partners 98.2%

Overall Employee Satisfaction

November 2026 Private Equity

  • Blackstone Group 99.6%
  • KKR (Kohlberg Kravis Roberts) 99.3%
  • The Riverside Company 98.9%
  • Ardian 98.5%
  • Warburg Pincus 98.1%

Professional Growth Opportunities

November 2026 Private Equity

  • Bain Capital 99.6%
  • Blackstone Group 99.3%
  • The Riverside Company 98.9%
  • Starwood Capital Group 98.5%
  • KKR (Kohlberg Kravis Roberts) 98.2%

Total Avg Compensation

November 2026 Private Equity

  • Principal (9) $653
  • Director/MD (24) $547
  • Vice President (100) $364
  • 3rd+ Year Associate (106) $280
  • 2nd Year Associate (236) $272
  • 1st Year Associate (414) $231
  • 3rd+ Year Analyst (33) $157
  • 2nd Year Analyst (97) $134
  • 1st Year Analyst (274) $126
  • Intern/Summer Associate (40) $79
  • Intern/Summer Analyst (357) $61
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Secyh62's picture
Secyh62
99.0
4
kanon's picture
kanon
99.0
5
GameTheory's picture
GameTheory
98.9
6
dosk17's picture
dosk17
98.9
7
Betsy Massar's picture
Betsy Massar
98.9
8
DrApeman's picture
DrApeman
98.9
9
CompBanker's picture
CompBanker
98.9
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”